Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 4

Review

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib

       
Total article views   HTML views PDF downloads Totals
20,107 Dovepress* 20,107+ 1,673 21,780
Totals 20,107 1,673 21,780
*Since 18 September 2014
+Since July 2016

View citations on Google Scholar